151. Hailey-Hailey disease: response to vitamin E therapy
- Author
-
Samuel Ayres
- Subjects
medicine.medical_specialty ,Exacerbation ,business.industry ,Vitamin E ,medicine.medical_treatment ,Dermatology ,General Medicine ,Disease ,medicine.disease ,Dermatitis repens ,Surgery ,Benign Chronic Pemphigus ,Hailey–Hailey disease ,Herpetiform ,Medicine ,Humans ,business ,Pemphigus - Abstract
To the Editor.— In the October 1982Archives(118:781-783) Michael presented a comprehensive commentary on the clinical, pathologic, etiologic, and therapeutic aspects of Hailey-Hailey disease, which is apparently associated with a genetic defect that was first reported by Hailey and Hailey in the April 1939Archivesunder the name "familial benign chronic pemphigus." 1 By a strange coincidence, the same condition was reported a few months later by Ayres and Anderson 2 in the September 1932Archivesunder the name "recurrent herpetiform dermatitis repens," five cases of which had been observed for more than 17 years. In 1975, Ayres and Mihan 3 reported the successful control of the conditions of three patients with Hailey-Hailey disease by the oral administration of vitamin E in the form of d-α-tocopheryl acetate in doses of 800 to 1,200 IU/day. Exacerbation occurred on several occasions when the dose was notably reduced or the treatment stopped
- Published
- 1983